SCHEMBL22260520

SCHEMBL22260520

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)c3ccccc3c3ccc5c(oc6ccc7ccccc7c65)c34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.43
CYP1A1 P04798 4/20 0.43
CYP1A2 P05177 4/20 0.43
PAX8 Q06710 2/20 0.43
FYN P06241 1/20 0.43
MAPK3 P27361 1/20 0.43
AHR P35869 1/20 0.43
ALDH1A1 P00352 4/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 4/20 0.37
CYP1B1 Q16678 3/20 0.37
KDM4E B2RXH2 2/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
PDE5A O76074 1/20 0.37
TP53 P04637 1/20 0.37
ABCB1 P08183 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22260519 1.00 ABCG2 (0.43) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22096998 0.92 ABCG2 (0.38) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22260179 0.88 ABCG2 (0.46) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22097102 0.88 ABCG2 (0.46) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22260185 0.87 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22097105 0.87 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22260525 0.87 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22097101 0.86 MEN1 (0.39) ABCG2CYP1A1CYP1A2ALDH1A1HPGD
SCHEMBL24028535 0.86 ABCG2 (0.42) ABCG2CYP1A1CYP1A2PAX8FYN
SCHEMBL22096997 0.86 ABCG2 (0.44) ABCG2CYP1A1CYP1A2PAX8FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, PIEZO1, SLCO4C1 ABCG2 757/4885CYP1A1 1422/4885CYP1A2 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.